Orencia and Hypersensitivity - a phase IV clinical study of FDA data
Hypersensitivity is found among people who take Orencia, especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months.
The phase IV clinical study analyzes which people take Orencia and have Hypersensitivity. It is created by eHealthMe based on reports of 108,994 people who have side effects when taking Orencia from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
108,994 people reported to have side effects when taking Orencia.
Among them, 8,175 people (7.5%) have Hypersensitivity.
What is Orencia?
Orencia has active ingredients of abatacept. It is often used in rheumatoid arthritis. eHealthMe is studying from 109,310 Orencia users for its effectiveness, alternative drugs and more.
What is Hypersensitivity?
Hypersensitivity is found to be associated with 3,378 drugs and 2,864 conditions by eHealthMe.
Number of Orencia and Hypersensitivity reports submitted per year:
Time on Orencia when people have Hypersensitivity *:
Gender of people who have Hypersensitivity when taking Orencia*:
Age of people who have Hypersensitivity when taking Orencia *:
Common drugs people take besides Orencia *:
Common side effects people have besides Hypersensitivity *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Orencia and have Hypersensitivity?Check whether Hypersensitivity is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Hypersensitivity and when was it recovered:
Expand to all the drugs that have ingredients of abatacept:
Alternative drugs to, pros and cons of Orencia:
- Orencia (109,310 reports)
Common Orencia side effects:
- Drug ineffective: 47,976 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 26,592 reports
- Pain: 19,503 reports
- Joint swelling: 17,226 reports
- Joint pain: 16,537 reports
- Rashes (redness): 13,951 reports
- Fatigue (feeling of tiredness): 13,326 reports
Browse all side effects of Orencia:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hypersensitivity treatments and more:
- Hypersensitivity (238,048 reports)
COVID vaccines that are related to Hypersensitivity:
- Hypersensitivity in Moderna COVID Vaccine
- Hypersensitivity in Pfizer BioNTech Covid Vaccine
- Hypersensitivity in Johnson and Johnson Covid Vaccine
Common drugs associated with Hypersensitivity:
- Enbrel: 13,291 reports
- Methotrexate: 12,945 reports
- Prednisone: 12,636 reports
- Humira: 11,185 reports
- Orencia: 8,175 reports
- Actemra: 8,085 reports
- Adapalene: 7,698 reports
- Remicade: 7,695 reports
- Arava: 6,319 reports
- Cimzia: 6,285 reports
All the drugs that are associated with Hypersensitivity:
- Hypersensitivity (3,378 drugs)
Common conditions associated with Hypersensitivity:
- Rheumatoid arthritis: 17,389 reports
- Multiple sclerosis: 8,176 reports
- Asthma: 6,520 reports
- High blood pressure: 5,656 reports
- Psoriasis: 4,121 reports
- Pain: 3,964 reports
- Acne: 3,557 reports
All the conditions that are associated with Hypersensitivity:
- Hypersensitivity (2,864 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on abatacept (the active ingredients of Orencia) and Orencia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Videx and Gestational Diabetes - now
- Diphenhydramine Hydrochloride and Nexium drug interaction - 3 seconds ago
- Loraz and Paroxetine drug interaction - 4 seconds ago
- Loraz and Urinary Bladder Haemorrhage - 5 seconds ago
- Orencia and Psoriatic Arthropathy - 6 seconds ago
- Neulasta and Albumin Globulin Ratio Decreased - 8 seconds ago
- Sulfasalazine and Chills - 8 seconds ago
- Abdominal Pain Lower and Tinnitus - 16 seconds ago
- Cyanocobalamin and Scar - 19 seconds ago
- Orencia and Musculoskeletal Stiffness - 27 seconds ago